peginterferon alfa 2b (Pegintron)

From Aaushi
Jump to navigation Jump to search

Introduction

Polyethylene-glycol modified interferon alfa 2b.

Tradename: Pegintron (FDA approved 2001)

Indications

Dosage

weekly SC injections

Pharmacokinetics

Adverse effects

Laboratory

Notes

Manufacturer: Schering-Plough

More general terms

More specific terms

Additional terms

Components

References

  1. Journal Watch 21(2):14, 2001
  2. Prescriber's Letter 8(2):8 2001
  3. 3.0 3.1 3.2 Medical Knowledge Self Assessment Program (MKSAP) 16 American College of Physicians, Philadelphia 2012
  4. 4.0 4.1 Deprecated Reference
  5. Department of Veterans Affairs, VA National Formulary
  6. 6.0 6.1 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline information for boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir and IFNL3. https://www.pharmgkb.org/guideline/PA166110235